Edition:
United States

Shire PLC (SHPG.OQ)

SHPG.OQ on NASDAQ Stock Exchange Global Select Market

178.15USD
18 Sep 2018
Change (% chg)

-- (--)
Prev Close
$178.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
302,232
52-wk High
$178.32
52-wk Low
$123.73

Chart for

About

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas... (more)

Overall

Beta: 1.21
Market Cap(Mil.): $54,003.77
Shares Outstanding(Mil.): 304.88
Dividend: 0.17
Yield (%): 0.60

Financials

  SHPG.OQ Industry Sector
P/E (TTM): 22.27 29.91 32.14
EPS (TTM): 8.00 -- --
ROI: 4.06 12.97 12.66
ROE: 7.16 14.97 14.84

UPDATE 1-UK Stocks-Factors to watch on Sept 17

(Adds company news items and futures) Britain's FTSE 100 index is seen opening 11 points lower at 7,293 on Monday, according to financial bookmakers, with FTSE 100 futures down 0.26 percent ahead of the cash market open.

Sep 17 2018

UK Stocks-Factors to watch on Sept 17

Britain's FTSE 100 index is seen opening 11 points lower at 7,293 on Monday, according to financial bookmakers. * GOLD: Gold inched up on Monday as bargain-hunters bought the metal after prices dipped in the previous session, amid reports that the United States is set to impose a new round of tariffs on Chinese imports. * OIL: Global oil prices eased in early Asian trading on Monday on concerns that the United States is poised to impose additional tariffs on China, outweighing supply fea

Sep 17 2018

UPDATE 1-FTSE tracks Europe higher; Shire shines

MILAN, Sept 14 Britain's top share index tracked higher European markets on Friday with the mood buoyed by easing trade worries, while Shire rose after China cleared Takeda's plans to buy the drugmaker.

Sep 14 2018

FTSE tracks Europe higher on trade hopes; Shire shines

MILAN, Sept 14 Britain's top share index tracked higher European markets on Friday with the mood buoyed by easing trade worries, while Shire rose after China cleared Takeda's plans to buy the drugmaker.

Sep 14 2018

Takeda gets China's approval for $62 billion Shire purchase

Takeda Pharmaceutical Co Ltd said on Friday China approved its purchase of Shire Plc, the latest regulator to clear the $62 billion deal and bring the Japanese group closer to becoming a global top 10 drugmaker.

Sep 14 2018

UPDATE 1-Takeda gets China's approval for $62 bln Shire purchase

* Takeda still awaiting approval from EU, Japan (Adds background, share price)

Sep 14 2018

Takeda gets China's approval for $62 bln Shire purchase

Sept 14 Japan's Takeda Pharmaceutical Co Ltd said on Friday China's market regulator had approved its $62 billion acquisition of Shire Plc, bringing it closer to becoming a global top 10 drugmaker.

Sep 14 2018

Takeda weighs sale of Shire's eye care business to cut debt: Bloomberg

Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday.

Sep 13 2018

Takeda weighs sale of Shire's eye care business to cut debt- Bloomberg

Sept 13 Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday.

Sep 13 2018

Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

Japan's Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the closing of its Shire Plc acquisition.

Sep 12 2018

Earnings vs. Estimates